Author

Stefan Wiemann

Primary ORCID profile (0000-0003-4683-3174 · 8 papers)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Stefan WiemanniD8 papers · German Cancer Research Center

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Organism:mouse· 1 Assay:multiome· 1 Assay:proteomics· 1

Frequent Co-Authors

Aysegul Uner· 1 shared Burcu Caliskan· 1 shared Erden Banoglu· 1 shared Kubra Ibis· 1 shared Meral Uner· 1 shared Mertkaya Aras· 1 shared Metin CetiniD· 1 shared Mustafa Emre GedikiD· 1 shared

Activity by Year

2023-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Aysegul Uner

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivPreprintSep 12, 2023

Reviving immunogenic cell death upon targeting TACC3 enhances T-DM1 response in HER2-positive breast cancer

Mustafa Emre Gedik, Ozge Saatci, Nathaniel Oberholtzer…·Ozgur Sahin

This study shows that T-DM1 induces immunogenic cell death (ICD) in HER2-positive breast cancer, which is lost in resistance, and that targeting TACC3 restores ICD and enhances T-DM1 response.

DOI 10.1101/2023.09.12.557273

mouseproteomics

𝕏 PostBluesky